JP2021505190A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021505190A5 JP2021505190A5 JP2020544990A JP2020544990A JP2021505190A5 JP 2021505190 A5 JP2021505190 A5 JP 2021505190A5 JP 2020544990 A JP2020544990 A JP 2020544990A JP 2020544990 A JP2020544990 A JP 2020544990A JP 2021505190 A5 JP2021505190 A5 JP 2021505190A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- cancer
- tumor
- specific
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1719169.3 | 2017-11-20 | ||
| GBGB1719169.3A GB201719169D0 (en) | 2017-11-20 | 2017-11-20 | Novel T-cell receptor and ligand |
| PCT/GB2018/053321 WO2019097244A1 (en) | 2017-11-20 | 2018-11-16 | Novel gamma delta t-cell receptor and its ligand |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021505190A JP2021505190A (ja) | 2021-02-18 |
| JP2021505190A5 true JP2021505190A5 (https=) | 2022-01-04 |
Family
ID=60805814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544990A Pending JP2021505190A (ja) | 2017-11-20 | 2018-11-16 | 新規γδ Ｔ細胞受容体及びそのリガンド |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11850264B2 (https=) |
| EP (1) | EP3713954A1 (https=) |
| JP (1) | JP2021505190A (https=) |
| KR (1) | KR20200085776A (https=) |
| CN (1) | CN111372944A (https=) |
| AU (1) | AU2018369698A1 (https=) |
| BR (1) | BR112020007469A2 (https=) |
| CA (1) | CA3079156A1 (https=) |
| EA (1) | EA202091276A1 (https=) |
| GB (1) | GB201719169D0 (https=) |
| IL (1) | IL274482A (https=) |
| MX (1) | MX2020005200A (https=) |
| SG (1) | SG11202002993UA (https=) |
| WO (1) | WO2019097244A1 (https=) |
| ZA (1) | ZA202002417B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230226183A1 (en) * | 2020-01-15 | 2023-07-20 | The Regents Of The University Of California | Compositions and methods for altering gamma delta t cell activity |
| EP4059955A1 (en) | 2021-03-19 | 2022-09-21 | Medizinische Hochschule Hannover | Hla-dr-specific gamma delta tcr constructs and use thereof |
| EP4472742A1 (en) | 2022-02-03 | 2024-12-11 | University College Cardiff Consultants Limited | Novel t-cell receptor |
| US20240043496A1 (en) * | 2022-07-26 | 2024-02-08 | Gadeta B.V. | Delta t-cell or gamma receptor chains or parts thereof for treating ovarian cancer |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260223A (en) * | 1986-07-03 | 1993-11-09 | President & Fellows Of Harvard College | Methods for detection of human gamma, γ T cell receptor |
| WO1996013593A2 (en) * | 1994-10-26 | 1996-05-09 | Procept, Inc. | Soluble single chain t cell receptors |
| WO1999060120A2 (en) | 1998-05-19 | 1999-11-25 | Avidex Limited | Soluble t cell receptor |
| AU2002308481A1 (en) * | 2001-05-01 | 2002-11-11 | Senomyx, Inc. | High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds |
| AU2002359666A1 (en) * | 2001-12-10 | 2003-06-23 | California Institute Of Technology | Method for the generation of antigen-specific lymphocytes |
| CN1842709A (zh) * | 2003-07-10 | 2006-10-04 | 塞诺米克斯公司 | 使用表达人的ENaC的卵母细胞的改进的电生理测定法和用于在使用膜电位报告染料的测定中提高ENaC增强子功效的PHENAMIL的用途 |
| WO2013155406A1 (en) * | 2012-04-12 | 2013-10-17 | The Chinese University Of Hong Kong | Contragestion and treating inflammation by modulating sodium channel activity in the epithelium |
| WO2015121454A1 (en) * | 2014-02-14 | 2015-08-20 | Cellectis | Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells |
| PL3119807T3 (pl) * | 2014-03-19 | 2019-09-30 | Cellectis | Specyficzne wobec cd123 chimeryczne receptory antygenowe do immunoterapii nowotworów |
| MX2016014434A (es) | 2014-05-13 | 2017-02-23 | Chugai Pharmaceutical Co Ltd | Molecula de union a antigeno redirigida a celulas t para celulas que tienen funcion de inmunosupresion. |
| WO2016016344A1 (en) | 2014-07-29 | 2016-02-04 | Cellectis | Ror1(ntrkr1)specific chimeric antigen receptors for cancer immunotherapy |
| DK3271382T3 (da) * | 2015-03-16 | 2020-05-04 | Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft | Fremgangsmåde til detektion af nye immunogene T-celleepitoper og isolering af nye antigenspecifikke T-cellereceptorer ved hjælp af et MHC-cellebibliotek |
-
2017
- 2017-11-20 GB GBGB1719169.3A patent/GB201719169D0/en not_active Ceased
-
2018
- 2018-11-16 SG SG11202002993UA patent/SG11202002993UA/en unknown
- 2018-11-16 EP EP18808079.0A patent/EP3713954A1/en active Pending
- 2018-11-16 EA EA202091276A patent/EA202091276A1/ru unknown
- 2018-11-16 KR KR1020207014073A patent/KR20200085776A/ko not_active Ceased
- 2018-11-16 AU AU2018369698A patent/AU2018369698A1/en not_active Abandoned
- 2018-11-16 BR BR112020007469-1A patent/BR112020007469A2/pt not_active IP Right Cessation
- 2018-11-16 MX MX2020005200A patent/MX2020005200A/es unknown
- 2018-11-16 CN CN201880074771.1A patent/CN111372944A/zh active Pending
- 2018-11-16 WO PCT/GB2018/053321 patent/WO2019097244A1/en not_active Ceased
- 2018-11-16 CA CA3079156A patent/CA3079156A1/en active Pending
- 2018-11-16 JP JP2020544990A patent/JP2021505190A/ja active Pending
-
2020
- 2020-05-04 ZA ZA2020/02417A patent/ZA202002417B/en unknown
- 2020-05-06 IL IL274482A patent/IL274482A/en unknown
- 2020-05-19 US US16/877,928 patent/US11850264B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021500406A5 (https=) | ||
| AU2021200091B2 (en) | Chimeric antigen receptor compositions | |
| CN113286879B (zh) | 用于细胞疗法之多样化抗原结合域、新颖平台及其他增强子 | |
| JP2021505190A5 (https=) | ||
| JP2022062277A (ja) | 増加した免疫活性において使用するためのａｃｔｒｉｉアンタゴニスト | |
| JP2024500847A5 (https=) | ||
| JP2021523110A (ja) | 遺伝子発現のためのナノ粒子及びその使用 | |
| JP2018510881A5 (https=) | ||
| CN109219445A (zh) | 嵌合抗原受体修饰细胞治疗癌症的应用 | |
| JP2025081512A (ja) | 血液がんおよび固形がんの治療のためのキメラ抗原受容体改変ｔ細胞（ｃａｒ－ｔ） | |
| JP2014509841A5 (https=) | ||
| JP2010531666A (ja) | 抗体−エンドスタチン融合タンパク質及びそのバリアント | |
| HRP20150256T1 (hr) | Djelatna sredstva za vezanje notch1-receptora i postupci njihove uporabe | |
| JP2015529641A5 (https=) | ||
| JP2021527425A5 (https=) | ||
| JP2020517248A (ja) | Ｌｒｉｇ‐１タンパク質に特異的な結合分子およびその用途 | |
| JP2024540275A5 (https=) | ||
| JP2021501567A5 (https=) | ||
| CN114364399A (zh) | 脑信号蛋白-4d阻断剂(sema4d)与dc1疗法的联合疗法 | |
| KR20250007062A (ko) | Epo 수용체 효능제 및 길항제 | |
| TW202328212A (zh) | Ｍａｇｅ—ａ４陽性癌症之治療 | |
| TW201806970A (zh) | 嵌合抗原受體、及其利用 | |
| JP2020150950A (ja) | 抗腫瘍剤及びその評価方法 | |
| JP2024505093A (ja) | 神経内分泌がんの治療 | |
| CN106963950B (zh) | 用于治疗肿瘤的联合用药物 |